Omeros (OMER)
(Delayed Data from NSDQ)
$3.90 USD
+0.01 (0.26%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $3.89 -0.01 (-0.26%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth C Momentum A VGM
Brokerage Reports
0 items in cart
Omeros Corporation [OMER]
Reports for Purchase
Showing records 421 - 423 ( 423 total )
Company: Omeros Corporation
Industry: Medical - Products
Q2 Financials Uneventful; However, In Our View Phase 3 Clinical Data Release In Q4 Could Result In Significant Upside.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Omeros Corporation
Industry: Medical - Products
Q1 Financials Uneventful; However, We Believe Clinical Data In H2 2010 Could Result In Significant Upside.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Omeros Corporation
Industry: Medical - Products
2009 Financials Uneventful; However, We Believe Additional Clinical Data In 2010 Could Result In Significant Upside
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L